Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20103002 | Senaparib | 1401682-78-7 | ≧98.0% |  |
| Senaparib (IMP4297) is a novel agent targeting PARP (poly-ADP ribose polymerase) with | ||||
| 20103004 | 2,6-difluoro-3,5-dimethoxybenzeneamine | 651734-54-2 | ≧98.0% |  |
| 2,6-difluoro-3,5-dimethoxybenzeneamine is a key intermeidate ofPemigatinib.1Kg~10Kg s | ||||
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot | ||||
| 26188 | Firibastat ( QGC-001 ) | 648927-86-0 | ≧98.0% |  |
| Firibastat, (originally named QGC001) is the first drug candidate of a new class of c | ||||
| 21224 | BI-187004 | 1303515-32-3 | ≧98.0% |  |
| BI-187004, also known as VTP-34072, is an 11β-hydroxysteroid dehydrogenase 1 inhibit | ||||
| 21236 | Centanafadine HCl | 923981-14-0 | ≧98.0% |  |
| Centanafadine, also known as EB-1020, is an adrenergic uptake inhibitor and dopamine | ||||
| 21237 | Centanafadine ( free base ) | 924012-43-1 | 98% Min. |  |
| Centanafadine (free base) is a dual norepinephrine-dopamine transporter inhibitor use | ||||
| 210507 | LP-261 | 915412-67-8 | ≧98.0% |  |
| LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine sit | ||||
| 21248 | Giredestrant | 1953133-47-5 | ≧98.0% |  |
| Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava | ||||
| 21252 | SM-102 | 2089251-47-6 | ≧98.0% |  |
| SM-102 is an ionizable amino lipid that has been used in combination with other lipid | ||||
| 21254 | 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-INDOLE | 690632-17-8 | 98% Min. |  |
| 21255 | 2,4-dimethoxy-6-methylnicotinonitrile | 1450662-05-1 | ≧95.0% |  |
| 2,4-dimethoxy-6-methylnicotinonitrile, is a key intermediate ofLirametostat ( CPI-120 | ||||